Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules

Exclusion Criteria

• •Blood biochemical indicators ALT, AST, BUN are greater than 1.5 times the upper limit of normal values, Cr is greater than the upper limit of normal values, eGFR\<60ml/min/1.73m2;
• •Alcoholic fatty liver, other chronic liver diseases, cirrhosis, liver malignant tumors, etc.;
• •Type 2 diabetes and pancreatic diseases;
• •Taking some hypoglycemic, lipid-lowering, liver protective drugs or high-dose vitamin E that may affect the efficacy judgment in the past three months;
• •Patients with severe infections, cardiovascular, respiratory, renal, hematological, rheumatic connective tissue disease, neuropsychiatric, and non liver malignant tumors;
• •Pregnant or lactating women;
• •Those who require long-term hormone therapy;
• •Researchers anticipate poor compliance or inability to cooperate;
• •There are contraindications for MRI examination, including pacemakers or cochlear implants, postoperative artificial valve replacement, presence of ferromagnetic vascular clips in the body, metal foreign bodies in the eyeball, insulin pumps, ferromagnetic objects in the scanning field, metal dentures, intrauterine devices, and patients with claustrophobia.